Eric Venker's Net Worth

$41.6 Million

Estimate Recalculated Nov 1, 2024 06:31AM EST

Who is Eric Venker?

Eric Venker has an estimated net worth of $41.6 Million. This is based on reported shares across multiple companies, which include Roivant Sciences Ltd., Arbutus Biopharma Corp, Immunovant, Inc., and Axovant Gene Therapies Ltd..

SEC CIK

Eric Venker's CIK is 0001801917

Past Insider Trading and Trends

2023 was Eric Venker's most active year for acquiring shares with 31 total transactions. Eric Venker's most active month to acquire stocks was the month of June. 2023 was Eric Venker's most active year for disposing of shares, totalling 76 transactions. Eric Venker's most active month to dispose stocks was the month of April. 2023 saw Eric Venker paying a total of $15,015,000.00 for 3,900,000 shares, this is the most they've acquired in one year. In 2023 Eric Venker cashed out on 8,104,366 shares for a total of $43,994,030.88, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Roivant Sciences Ltd. (ROIV) Snapshot price: $12.4

President & COO

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-1.74%
-10.95K
$7.77
-$910,464.40
617.47K
Oct 20 - Oct 21
Form 4
-1.68%
-10.95K
$11.48
-$125,671.56
639.36K
Aug 20
Form 4
+45.71%
204K
—
—
650.31K
Jul 26
Form 4
-2.39%
-10.95K
$11.00
-$120,395.00
446.31K
Jul 20
Form 4
-2.34%
-10.95K
$10.80
-$118,206.00
457.25K
Jun 20
Form 4
-3.31%
-16.00K
$11.37
-$181,954.11
468.2K
May 20
Form 4
-3.20%
-16.00K
$10.46
-$167,380.92
484.2K
Apr 20
Form 4
-3.10%
-16.00K
$10.01
-$160,190.03
500.2K
Mar 20
Form 4
-3.01%
-16.00K
$11.54
-$184,663.08
516.21K
Feb 20
Form 4
—
0
$7.39
-$685,436.50
532.21K
Feb 9
Form 4
-2.27%
-12.38K
$10.35
-$128,101.95
532.21K
Jan 20
Form 4
-2.85%
-16.00K
$9.96
-$159,389.88
544.58K
Dec 20
Form 4
-2.87%
-16.55K
$8.68
-$143,645.32
560.59K
Nov 22
Form 4
-3.07%
-18.26K
$8.99
-$164,166.39
577.14K
Oct 24
Form 4
—
0
$7.14
-$7,900,989.82
595.4K
Oct 2 - Oct 5
Form 4
—
0
$8.44
-$4,585,000.00
595.4K
Sep 27
Form 4
-2.68%
-16.42K
$10.19
-$167,279.04
595.4K
Sep 22
Form 4
—
0
$8.02
-$887,626.20
611.81K
Sep 8
Form 4
—
0
$7.88
-$757,579.40
611.81K
Sep 1 - Sep 6
Form 4
-2.56%
-16.11K
$10.83
-$174,417.15
611.81K
Aug 22
Form 4
—
0
$7.87
-$480,880.44
627.92K
Aug 14
Form 4
—
0
$7.89
-$360,602.32
627.92K
Aug 3
Form 4
—
0
$7.88
-$1,572,832.08
627.92K
Jul 31 - Aug 2
Form 4
—
0
$7.38
-$886,506.38
627.92K
Jul 25 - Jul 27
Form 4
-2.53%
-16.30K
$7.52
-$2,927,289.97
627.92K
Jul 20 - Jul 24
Form 4
-2.41%
-15.88K
$10.01
-$158,978.82
644.22K
Jun 22
Form 4
—
0
$6.88
-$1,815,473.04
660.1K
Jun 7 - Jun 9
Form 4
-2.32%
-15.67K
$6.72
-$152,618.18
660.1K
May 23
Form 4
—
0
$6.54
-$1,284,335.12
675.77K
May 9
Form 4
—
0
$6.21
-$706,255.58
675.77K
May 4 - May 8
Form 4
—
0
$6.13
-$1,314,521.26
675.77K
May 1 - May 3
Form 4
—
0
$6.20
-$1,043,555.36
675.77K
Apr 26 - Apr 28
Form 4
-2.09%
-14.46K
$8.80
-$127,221.60
675.77K
Apr 20
Form 4
-2.01%
-14.19K
$7.30
-$103,616.20
690.23K
Mar 23
Form 4
-1.67%
-11.95K
$8.43
-$100,763.79
704.42K
Scheduled
Feb 22
Form 4
-1.79%
-13.06K
$8.56
-$111,767.92
716.37K
Scheduled
Jan 24
Form 4
-3.19%
-24.04K
$8.02
-$192,776.74
729.43K
Scheduled
Jan 5
Form 4
-13.66%
-119.25K
$7.46
-$889,030.88
753.47K
Scheduled
Dec 30 - Jan 3
Form 4
-1.75%
-16.03K
$7.10
-$113,820.10
901.65K
Scheduled
Dec 23
Form 4
-14.04%
-145.10K
$7.03
-$1,019,736.28
888.74K
Scheduled
Dec 8 - Dec 9
Form 4
-1.52%
-16.00K
$5.00
-$80,015.00
1.03M
Nov 20
Form 4
-1.49%
-15.92K
$4.40
-$70,056.80
1.05M
Scheduled
Oct 25
Form 4
-1.61%
-17.39K
$3.07
-$53,393.44
1.07M
Scheduled
Sep 23
Form 4
-1.50%
-16.53K
$3.71
-$61,326.30
1.08M
Scheduled
Aug 24
Form 4
-1.51%
-16.90K
$4.33
-$73,159.68
1.1M
Scheduled
Jul 25
Form 4
-1.45%
-16.40K
$4.34
-$71,184.68
1.12M
Scheduled
Jun 23
Form 4
-10.75%
-136.42K
$3.70
-$504,757.70
1.13M
May 20
Form 4
-0.40%
-5.11K
$3.84
-$19,610.88
1.27M
Scheduled
Apr 25
Form 4
—
0
—
—
0
Apr 20
Form 4
-2.63%
-34.43K
$4.80
-$165,122.32
1.27M
Scheduled
Mar 30
Form 4
-5.76%
-80.05K
$5.06
-$405,027.70
1.31M
Scheduled
Mar 25
Form 3
—
0
—
—
0
No matching records found

Arbutus Biopharma Corp (ABUS) Snapshot price: $4.5488

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
—
0
—
—
0
No matching records found

Immunovant, Inc. (IMVT) Snapshot price: $34

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
—
0
—
—
0
No matching records found

Axovant Gene Therapies Ltd. (SIOX) Snapshot price: $0.45

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
—
0
—
—
0
No matching records found